| NDC Code: |
47335-049 |
| Proprietary Name: |
Doxorubicin Hydrochloride |
| Suffix: |
|
| Non-Proprietary Name: |
Doxorubicin Hydrochloride |
| Dosage Form: |
INJECTABLE, LIPOSOMAL |
| Method: |
INTRAVENOUS |
| Original Marketing Date: |
05-02-2013 |
| Category Name: |
ANDA |
| Application Number: |
ANDA203263 |
| Labeler: |
SUN PHARMA GLOBAL FZE |
| Substance Name: |
DOXORUBICIN HYDROCHLORIDE |
| Active Numerator Strength: |
2 |
| Active Ingredient Unit: |
mg/mL |
| Pharm Classes: |
Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
| DEA Schedule: |
|
